Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery-Reference-Cited by-同舟云学术

Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery

Published:2013-11 Issue:1 Volume:172 Page:179-189
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Wang Yuhua,Zhang Lu,Guo Shutao,Hatefi Arash,Huang Leaf

Funder

NIH

Department of Defense Prostate Cancer New Investigator Award

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans;Fire;Nature,1998

2. Knocking down barriers: advances in siRNA delivery;Whitehead;Nat. Rev. Drug Discov.,2009

3. Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells;Chen;Mol. Pharm.,2009

4. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor;Chono;J. Control. Release,2008

5. Tumor-targeted delivery of siRNA by self-assembled nanoparticles;Li;Mol. Ther. J. Am. Soc. Gene Ther.,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-responsive liposomes for controlled drug release;Drug Discovery Today;2024-07

2. An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer;Current Drug Delivery;2024-05

3. A nanotherapeutic approach for fighting the odds against the malignant disorders;Journal of Nanoparticle Research;2023-05-31

4. Creating Artificial Viruses Using Self-assembled Proteins and Polypeptides;Physical Virology;2023

5. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force;Seminars in Cancer Biology;2021-02